Does Combination Therapy With Vancomycin and Piperacillin-Tazobactam Increase the Risk of Nephrotoxicity Versus Vancomycin Alone in Pediatric Patients?

OBJECTIVES: To determine if the incidence of nephrotoxicity is higher in pediatric patients treated with the combination of vancomycin and piperacillin-tazobactam, compared to patients treated with vancomycin alone. Secondary objectives were to determine if admission to an intensive care unit (ICU),...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Pediatr Pharmacol Ther
Main Authors: McQueen, Katherine E., Clark, Dana W.
Formato: Artigo
Idioma:Inglês
Publicado: Pediatric Pharmacy Advocacy Group 2016
Assuntos:
Clinical Investigations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040177/
https://ncbi.nlm.nih.gov/pubmed/27713673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-21.4.332
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares